University of California, Santa Barbara |
Bernadette McCafferty |
Patent Assistance Fund Awards |
Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara. |
$23,564 |
Human BioMolecular Research Institute |
John Cashman |
Patent Assistance Fund Awards |
Intellectual Property for Stem Cell-Related Inventions - HBRI |
$50,000 |
Brain Mapping Foundation |
Babak Kateb |
Conference |
8th Annual World Congress for Brain, Spinal Cord Mapping and Image Guided Therapy at Mission Bay Conference Center of UCSF School of Medicine |
$17,200 |
University of California, Los Angeles |
Ali Nsair |
Basic Biology III |
Characterization and Engineering of the Cardiac Stem Cell Niche |
$1,127,741 |
University of California, San Diego |
David Cheresh |
Basic Biology III |
Molecular basis of human ES cell neurovascular differentiation and co-patterning |
$1,359,996 |
University of California, Los Angeles |
Gay Crooks |
Basic Biology III |
Forming the Hematopoietic Niche from Human Pluripotent Stem Cells |
$1,252,857 |
University of California, San Diego |
Anirvan Ghosh |
Basic Biology III |
Investigation of synaptic defects in autism using patient-derived induced pluripotent stem cells |
$843,597 |
Stanford University |
Aaron Hsueh |
Basic Biology III |
Correlated time-lapse imaging and single cell molecular analysis of human embryo development |
$1,259,733 |
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
Stanford University |
Joanna Wysocka |
Basic Biology III |
Enhancer-mediated gene regulation during early human embryonic development |
$1,420,618 |
University of California, San Diego |
Farah Sheikh |
Basic Biology III |
Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC |
$1,341,955 |
University of California, San Diego |
Charles King |
Basic Biology III |
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas |
$1,313,649 |
Stanford University |
Sean Wu |
Basic Biology III |
Elucidating Molecular Basis of Hypertrophic Cardiomyopathy with Human Induced Pluripotent Stem Cells |
$1,260,537 |
Gladstone Institutes, J. David |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,572,380 |
Scripps Research Institute |
Joel Gottesfeld |
Basic Biology III |
Triplet Repeat Instability in Human iPSCs |
$1,705,494 |
University of California, San Diego |
Binhai Zheng |
Basic Biology III |
Generation and characterization of corticospinal neurons from human embryonic stem cells |
$1,355,063 |
University of California, San Francisco |
Jason Pomerantz |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$677,115 |
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,378,781 |
Stanford University |
Michael Clarke |
Basic Biology III |
USP16 controls stem cell number: implications for Down Syndrome |
$1,263,826 |
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,705,500 |
University of California, San Diego |
Deborah Spector |
Basic Biology III |
Viral-host interactions affecting neural differentiation of human progenitors |
$1,372,660 |
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,070,919 |
University of California, San Diego |
Kun Zhang |
Basic Biology III |
Functional characterization of mutational load in nuclear reprogramming and differentiation |
$1,295,318 |
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,224,805 |
City of Hope, Beckman Research Institute |
Jiing-Kuan Yee |
Basic Biology III |
Use of human iPS cells to study spinal muscular atrophy |
$1,268,868 |
Parkinson's Institute |
R. Jeremy Nichols |
Basic Biology III |
Understanding the role of LRRK2 in iPSC cell models of Parkinson's Disease |
$1,482,822 |
University of California, Berkeley |
Song Li |
Basic Biology III |
Induced Pluripotent Stem Cells for Tissue Regeneration |
$1,209,148 |
University of California, San Diego |
Eugene Yeo |
Basic Biology III |
Neural and general splicing factors control self-renewal, neural survival and differentiation |
$1,287,619 |
University of California, Santa Barbara |
Francis Doyle |
Conference |
12th Annual Systemwide Bioengineering Symposium |
$15,000 |
Cedars-Sinai Medical Center |
John Yu |
Conference |
First Annual Stem Cell Therapies for Neurological Disorders: Overcoming the Current Barriers to Clinical Translation, April 30 (special stem cell program for high school students on April 28) |
$18,500 |
City of Hope, Beckman Research Institute |
Fouad Kandeel |
Conference |
2011 Rachmiel Levine Diabetes and Obesity Symposium: Advances in Diabetes Research |
$15,000 |
University of California, San Diego |
Lawrence Goldstein |
Tools and Technologies II |
Developing a method for rapid identification of high-quality disease specific hIPSC lines |
$1,686,069 |
Stanford University |
Sarah Heilshorn |
Tools and Technologies II |
Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels |
$600,695 |
GMR Epigenetics |
Jifan Hu |
Tools and Technologies II |
Robust generation of induced pluripotent stem cells by a potent set of engineered factors |
$1,356,052 |
Parkinson's Institute |
Birgitt Schuele |
Tools and Technologies II |
Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases |
$1,327,983 |
University of California, San Francisco |
Daniel Lim |
Tools and Technologies II |
Development and preclinical testing of new devices for cell transplantation to the brain. |
$1,795,891 |
University of California, Los Angeles |
Martin Martin |
Tools and Technologies II |
Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders |
$1,783,250 |
Stanford University |
Brian Rutt |
Tools and Technologies II |
Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters |
$1,833,348 |
University of California, Berkeley |
David Schaffer |
Tools and Technologies II |
Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs |
$1,340,816 |
Cedars-Sinai Medical Center |
Clive Svendsen |
Tools and Technologies II |
Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. |
$1,933,022 |
Fluidigm Corporation |
Marc Unger |
Tools and Technologies II |
Development and Application of Versatile, Automated, Microfluidic Cell Culture System |
$1,939,236 |
Stanford University |
Michele Calos |
Tools and Technologies II |
Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation |
$1,592,897 |
TriFoil Imaging, Inc. |
Joann Zhang |
Tools and Technologies II |
Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring |
$1,456,989 |
University of California, Los Angeles |
Stanley Carmichael |
Tools and Technologies II |
Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke |
$1,825,613 |
Stanford University |
Irving Weissman |
Tools and Technologies II |
Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs |
$1,463,814 |
University of California, San Diego |
Shu Chien |
Tools and Technologies II |
Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation |
$1,706,628 |
Stanford University |
Marius Wernig |
Tools and Technologies II |
Cellular tools to study brain diseases affecting synaptic transmission |
$1,664,382 |
University of California, Berkeley |
Steven Conolly |
Tools and Technologies II |
Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo |
$1,311,596 |
University of California, San Diego |
Karl Willert |
Tools and Technologies II |
Homologous recombination in human pluripotent stem cells using adeno-associated virus. |
$1,659,043 |
Stanford University |
Theo Palmer |
Tools and Technologies II |
Development of small molecule screens for autism using patient-derived iPS cells |
$1,797,606 |
University of California, Los Angeles |
Richard Gatti |
Tools and Technologies II |
Use of hiPSCs to develop lead compounds for the treatment of genetic diseases |
$1,833,054 |
Gordon Research Conferences |
Catriona Jamieson |
Conference |
2011 Gordon Conference on Stem Cells and Cancer |
$40,000 |
Sanford Consortium for Regenerative Medicine |
Edward Holmes |
Conference |
Stem Cell Meeting on Mesa |
$40,000 |
University of California, Los Angeles |
Irvin Chen |
Conference |
Stem Cells: A New Avenue of HIV Research and New Approaches to HIV Treatment |
$24,456 |
University of California, Davis |
Alice Tarantal |
Conference |
9th Annual Gene Therapy Symposium for Heart, Lung and Blood Diseases |
$12,000 |
City of Hope, Beckman Research Institute |
Richard Jove |
Conference |
New Approaches in Cell Based Therapies |
$20,000 |
Scripps Research Institute |
Peter Schultz |
Early Translational II |
Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis |
$6,047,249 |
iPierian, Inc. |
John Dimos |
Early Translational II |
New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells |
$2,410,000 |
University of California, Davis |
Roslyn Isseroff |
Early Translational II |
Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds |
$4,629,747 |
University of California, San Francisco |
Markus Muschen |
Early Translational II |
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication |
$2,756,536 |
University of California, San Francisco |
Arturo Alvarez-Buylla |
Early Translational II |
Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy |
$1,564,016 |
University of California, Los Angeles |
Bruno Peault |
Early Translational II |
Harnessing native fat-residing stem cells for bone regeneration |
$5,359,076 |
University of California, Irvine |
Brian Cummings |
Early Translational II |
Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury |
$1,517,767 |
Cedars-Sinai Medical Center |
Dan Gazit |
Early Translational II |
Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures |
$1,927,698 |
University of California, Los Angeles |
Sophie Deng |
Early Translational II |
Regeneration of Functional Human Corneal Epithelial Progenitor Cells |
$697,507 |
City of Hope, Beckman Research Institute |
Yanhong Shi |
Early Translational II |
Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell |
$1,835,983 |
Stanford University |
Michele Calos |
Early Translational II |
Stem Cell Therapy for Duchenne Muscular Dystrophy |
$2,267,261 |
Buck Institute for Age Research |
Xianmin Zeng |
Early Translational II |
Banking transplant ready dopaminergic neurons using a scalable process |
$4,983,013 |
University of California, Irvine |
leif Havton |
Early Translational II |
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons |
$1,527,011 |
University of California, Davis |
Mark Zern |
Early Translational II |
Liver Cell Transplantation |
$4,212,621 |
Salk Institute for Biological Studies |
Fred Gage |
Early Translational II |
Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model |
$2,472,839 |
University of California, Los Angeles |
Noriyuki Kasahara |
Early Translational II |
Stem cell-based carriers for RCR vector delivery to glioblastoma |
$3,340,625 |
Children's Hospital of Los Angeles |
Markus Muschen |
Early Translational II |
Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication |
$850,769 |
University of California, San Diego |
Catriona Jamieson |
Early Translational II |
Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy |
$3,103,041 |
University of California, Los Angeles |
Leif Havton |
Early Translational II |
Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons |
$75,628 |
University of California, Irvine |
Leslie Thompson |
Early Translational II |
A hESc-based Development Candidate for Huntington's Disease |
$3,955,038 |
University of California, San Diego |
Alysson Muotri |
Early Translational II |
Developing a drug-screening system for Autism Spectrum Disorders using human neurons |
$1,376,198 |
City of Hope, Beckman Research Institute |
David DiGiusto |
Early Translational II |
Development of RNA-based approaches to stem cell gene therapy for HIV |
$3,097,160 |
University of California, Los Angeles |
Sophie Deng |
Early Translational II |
Regeneration of Functional Human Corneal Epithelial Progenitor Cells |
$1,524,947 |
University of California, Santa Barbara |
Peter Coffey |
Research Leadership |
Development of Cellular Therapies for Retinal Disease |
$4,690,963 |
University of California, Irvine |
Henry Klassen |
Early Translational II |
Human retinal progenitor cells as candidate therapy for retinitis pigmentosa |
$1,803,768 |
Vitalant Research Institute |
Elizabeth Read |
Conference |
Translation of Stem Cell Therapies: Strategies and Best Practices for PreClinical Developments |
$25,000 |
University of California, San Francisco |
Emmanuelle Passegue |
Conference |
CA-HSCI 1st Generation Stem Cell PI Meeting |
$20,000 |
International Society for Stem Cell Research |
Irving Weissman |
Conference |
ISSCR 8th Annual Meeting - San Francisco |
$62,475 |
Sanford Burnham Prebys Medical Discovery Institute |
Robert Wechsler-Reya |
Research Leadership |
The role of neural stem cells in cerebellar development, regeneration and tumorigenesis |
$5,226,049 |
University of California, San Francisco |
Mark Anderson |
Transplantation Immunology |
Stem cell differentiation to thymic epithelium for inducing tolerance to stem cells |
$1,314,089 |
University of Southern California |
Terrence Town |
Transplantation Immunology |
Role of HLA in neural stem cell rejection using humanized mice |
$353,249 |
Stanford University |
Aaron Hsueh |
Basic Biology II |
Maturation of Human Oocytes for SCNT and Embryonic Stem Cell Derivation |
$1,309,018 |
University of California, San Francisco |
Jeffrey Bluestone |
Transplantation Immunology |
Stem cell tolerance through the use of engineered antigen-specific regulatory T cells |
$1,152,768 |
Stanford University |
Kenneth Weinberg |
Transplantation Immunology |
Engineered immune tolerance by Stem Cell-derived thymic regeneration |
$1,271,729 |
Salk Institute for Biological Studies |
Ronald Evans |
Basic Biology II |
Molecular Characterization and Functional Exploration of Nuclear Receptors in hiPSCs |
$1,712,880 |
Stanford University |
Christopher Contag |
Transplantation Immunology |
Engineering Embryonic Stem Cell Allografts for Operational Tolerance |
$1,411,338 |
University of California, San Diego |
Yang Xu |
Transplantation Immunology |
Induction of immune tolerance to human embryonic stem cell-derived allografts |
$1,192,680 |
iPierian, Inc. |
Irene Griswold-Prenner |
Basic Biology II |
Cellular Reprogramming: Dissecting the Molecular Mechanism and Enhancing Efficiency |
$1,458,000 |
University of California, Los Angeles |
Gay Crooks |
Transplantation Immunology |
Engineering Thymic Regeneration to Induce Tolerance |
$1,235,445 |
University of California, Davis |
Eric Kurzrock |
Basic Biology II |
Differentiation of Human Embryonic Stem Cells into Urothelium |
$849,037 |
Scripps Research Institute |
Nicholas Gascoigne |
Transplantation Immunology |
Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance |
$1,705,554 |
Palo Alto Veterans Institute for Research |
Tony Wyss-Coray |
Basic Biology II |
Systemic Protein Factors as Modulators of the Aging Neurogenic Niche |
$1,159,806 |